Next Article in Journal
Short-Term Lincomycin Exposure Depletion of Murine Microbiota Affects Short-Chain Fatty Acids and Intestinal Morphology and Immunity
Previous Article in Journal
Use of Oral Tetracyclines in the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia: A Literature Review on the Often-Overlooked Antibiotic Class
Open AccessArticle

Simultaneous Control of Staphylococcus aureus and Bacillus cereus Using a Hybrid Endolysin LysB4EAD-LysSA11

by 1,2, 3, 1,2, 4 and 1,2,5,6,*
1
Department of Food and Animal Biotechnology, Seoul National University, Seoul 08826, Korea
2
Department of Agricultural Biotechnology, Seoul National University, Seoul 08826, Korea
3
Department of Food Science and Technology, Seoul National University of Science and Technology, Seoul 01811, Korea
4
Division of Applied Food System, Food Science & Technology, Seoul Women’s University, Seoul 01797, Korea
5
Research Institute of Agriculture and Life Sciences, Seoul National University, Seoul 08826, Korea
6
Center for Food and Bioconvergence, Seoul National University, Seoul 08826, Korea
*
Author to whom correspondence should be addressed.
Antibiotics 2020, 9(12), 906; https://doi.org/10.3390/antibiotics9120906
Received: 24 November 2020 / Revised: 8 December 2020 / Accepted: 11 December 2020 / Published: 14 December 2020
Bacteriophage endolysins have attracted attention as promising alternatives to antibiotics, and their modular structure facilitates endolysin engineering to develop novel endolysins with enhanced versatility. Here, we constructed hybrid proteins consisting of two different endolysins for simultaneous control of two critical foodborne pathogens, Staphylococcus aureus and Bacillus cereus. The full-length or enzymatically active domain (EAD) of LysB4, an endolysin from the B. cereus-infecting phage B4, was fused to LysSA11, an endolysin of the S. aureus-infecting phage SA11, via a helical linker in both orientations. The hybrid proteins maintained the lytic activity of their parental endolysins against both S. aureus and B. cereus, but they showed an extended antimicrobial spectrum. Among them, the EAD of LysB4 fused with LysSA11 (LysB4EAD-LyaSA11) showed significantly increased thermal stability compared to its parental endolysins. LysB4EAD-LysSA11 exhibited high lytic activity at pH 8.0–9.0 against S. aureus and at pH 5.0–10.0 against B. cereus, but the lytic activity of the protein decreased in the presence of NaCl. In boiled rice, treatment with 3.0 µM of LysB4EAD-LysSA11 reduced the number of S. aureus and B. cereus to undetectable levels within 2 h and also showed superior antimicrobial activity to LyB4EAD and LysSA11 in combination. These results suggest that LysB4EAD-LysSA11 could be a potent antimicrobial agent for simultaneous control of S. aureus and B. cereus. View Full-Text
Keywords: endolysin; protein engineering; hybrid protein; biocontrol agent endolysin; protein engineering; hybrid protein; biocontrol agent
Show Figures

Graphical abstract

MDPI and ACS Style

Son, B.; Kong, M.; Cha, Y.; Bai, J.; Ryu, S. Simultaneous Control of Staphylococcus aureus and Bacillus cereus Using a Hybrid Endolysin LysB4EAD-LysSA11. Antibiotics 2020, 9, 906. https://doi.org/10.3390/antibiotics9120906

AMA Style

Son B, Kong M, Cha Y, Bai J, Ryu S. Simultaneous Control of Staphylococcus aureus and Bacillus cereus Using a Hybrid Endolysin LysB4EAD-LysSA11. Antibiotics. 2020; 9(12):906. https://doi.org/10.3390/antibiotics9120906

Chicago/Turabian Style

Son, Bokyung; Kong, Minsuk; Cha, Yoyeon; Bai, Jaewoo; Ryu, Sangryeol. 2020. "Simultaneous Control of Staphylococcus aureus and Bacillus cereus Using a Hybrid Endolysin LysB4EAD-LysSA11" Antibiotics 9, no. 12: 906. https://doi.org/10.3390/antibiotics9120906

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop